BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 11940464)

  • 21. Development of a hypoxia-responsive vector for tumor-specific gene therapy.
    Shibata T; Giaccia AJ; Brown JM
    Gene Ther; 2000 Mar; 7(6):493-8. PubMed ID: 10757022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A.
    Detwiller KY; Fernando NT; Segal NH; Ryeom SW; D'Amore PA; Yoon SS
    Cancer Res; 2005 Jul; 65(13):5881-9. PubMed ID: 15994966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein kinases and the hypoxia-inducible factor-1, two switches in angiogenesis.
    Mazure NM; Brahimi-Horn MC; Pouysségur J
    Curr Pharm Des; 2003; 9(7):531-41. PubMed ID: 12570801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of hypoxia-induced angiogenesis: a chaperone escorts VEGF to the dance.
    Semenza GL
    J Clin Invest; 2001 Jul; 108(1):39-40. PubMed ID: 11435455
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors.
    Chau NM; Rogers P; Aherne W; Carroll V; Collins I; McDonald E; Workman P; Ashcroft M
    Cancer Res; 2005 Jun; 65(11):4918-28. PubMed ID: 15930314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biomedicine. Clotting factors build blood vessels.
    Carmeliet P
    Science; 2001 Aug; 293(5535):1602-4. PubMed ID: 11533466
    [No Abstract]   [Full Text] [Related]  

  • 28. Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition.
    Dang DT; Chun SY; Burkitt K; Abe M; Chen S; Havre P; Mabjeesh NJ; Heath EI; Vogelzang NJ; Cruz-Correa M; Blayney DW; Ensminger WD; St Croix B; Dang NH; Dang LH
    Cancer Res; 2008 Mar; 68(6):1872-80. PubMed ID: 18339868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of hypoxia inducible factor-1alpha with lymphatic metastasis via vascular endothelial growth factor-C in human esophageal cancer.
    Katsuta M; Miyashita M; Makino H; Nomura T; Shinji S; Yamashita K; Tajiri T; Kudo M; Ishiwata T; Naito Z
    Exp Mol Pathol; 2005 Apr; 78(2):123-30. PubMed ID: 15713437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diosgenin induces hypoxia-inducible factor-1 activation and angiogenesis through estrogen receptor-related phosphatidylinositol 3-kinase/Akt and p38 mitogen-activated protein kinase pathways in osteoblasts.
    Yen ML; Su JL; Chien CL; Tseng KW; Yang CY; Chen WF; Chang CC; Kuo ML
    Mol Pharmacol; 2005 Oct; 68(4):1061-73. PubMed ID: 15998873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Capsaicin regulates vascular endothelial cell growth factor expression by modulation of hypoxia inducing factor-1alpha in human malignant melanoma cells.
    Patel PS; Yang S; Li A; Varney ML; Singh RK
    J Cancer Res Clin Oncol; 2002 Sep; 128(9):461-8. PubMed ID: 12242509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.
    Menendez JA; Vellon L; Oza BP; Lupu R
    J Cell Biochem; 2005 Apr; 94(5):857-63. PubMed ID: 15669079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor is regulated by hypoxic stress via MAPK and HIF-1 alpha in the inner ear.
    Jeong HJ; Kim JB; Hong SH; An NH; Kim MS; Park BR; Park RK; Kim HM
    J Neuroimmunol; 2005 Jun; 163(1-2):84-91. PubMed ID: 15885310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells.
    Knowles HJ; Raval RR; Harris AL; Ratcliffe PJ
    Cancer Res; 2003 Apr; 63(8):1764-8. PubMed ID: 12702559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1.
    Krishnamachary B; Berg-Dixon S; Kelly B; Agani F; Feldser D; Ferreira G; Iyer N; LaRusch J; Pak B; Taghavi P; Semenza GL
    Cancer Res; 2003 Mar; 63(5):1138-43. PubMed ID: 12615733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Vascular endothelial growth factor VEGF stimulates angiogenesis in good and bad situations].
    Heits F; Wiedemann GJ; Jelkmann W
    Dtsch Med Wochenschr; 1998 Feb; 123(9):259-65. PubMed ID: 9524537
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of ERK and calcium in the hypoxia-induced activation of HIF-1.
    Mottet D; Michel G; Renard P; Ninane N; Raes M; Michiels C
    J Cell Physiol; 2003 Jan; 194(1):30-44. PubMed ID: 12447987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute intravesical infusion of a cobalt solution stimulates a hypoxia response, growth and angiogenesis in the rat bladder.
    Buttyan R; Chichester P; Stisser B; Matsumoto S; Ghafar MA; Levin RM
    J Urol; 2003 Jun; 169(6):2402-6. PubMed ID: 12771806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting HIF-1 for cancer therapy.
    Semenza GL
    Nat Rev Cancer; 2003 Oct; 3(10):721-32. PubMed ID: 13130303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1?
    Burroughs KD; Oh J; Barrett JC; DiAugustine RP
    Mol Cancer Res; 2003 Feb; 1(4):312-22. PubMed ID: 12612059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.